Skip to content

Evaluating the Efficacy of Wheat Grain Moxibustion on Jing Points for Antituberculous-Induced Peripheral Neuropathy in Elderly Patients with Pulmonary Tuberculosis:Study Protocol for a Randomized Controlled Trial

A Randomized Controlled Study on the Treatment of Antituberculous-Induced Peripheral Neuropathy in Elderly Patients with Pulmonary Tuberculosis Using Wheat Grain Moxibustion on Jing Points

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001074
Enrollment
Unknown
Registered
2025-05-28
Start date
2024-07-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary tuberculosis

Interventions

Control group:On the basis of conventional anti-tuberculosis treatment, participants in the control group will be treated with oral Vitamin B6 (Vit B6) tablets,50 mg (5 tablets) each, three times a da
Treatment group:On the basis of the control group, wheat grain moxibustion was given. Prescriptions of acupoints:Jing Points,Zusanli(ST36).One point uses five moxa cones, every other day, three times

Sponsors

Lishui Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria for pulmonary tuberculosis in Western medicine and fulfill the diagnostic standards for "Ma Mu" (numbness and tingling) in Traditional Chinese Medicine;   2.PN symptoms occur after using antituberculous drugs. 3.Age = 60 years. 4.Patients have satisfactory compliance and are willing to enroll in the trial and sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1.Multidrug-resistant tuberculosis patientsPN caused by other diseases such as diabetic peripheral neuropathy;The patient had obvious PN symptoms before using isoniazid. 2.age < 60 years. 3.Patients have severe complications in hematopoietic liver and kidney. 4.Participating in other clinical trials. 5.Had received acupuncture for this disease in last 30days prior to participation in this study. 6. Treatment area is infected.

Design outcomes

Primary

MeasureTime frame
Total Neuropathy Score;

Secondary

MeasureTime frame
Patient Neurotoxicity Questionnaire;Indicators for Evaluating the Efficacy of Chinese Medicine Symptoms;Hospital Anxiety and Depression Scale;

Countries

China

Contacts

Public ContactYejing Shen

Lishui Hospital of Traditional Chinese Medicine

867135484@qq.com+86-17858199581

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026